Hemorrhage and Hematology

Tracheoinnominate artery fistula (Review)

A dreaded but rare complication, tracheoarterial fistulas elude systematic study

Feb 16 • PulmCCM

Nebulized tranexamic acid for hemoptysis (Research Review)

How good is the evidence, and how much should we care?

Feb 2 • PulmCCM

The Real-World Boards: Question #21

A 48-year-old man with ESRD and a new pleural effusion

Dec 5, 2025 • PulmCCM

The Latest in Critical Care: November 26, 2025

"Permissive hypotension" in the OR; TOP trial for RBC transfusion; TXA for hemoptysis

Nov 26, 2025 • PulmCCM

Arterial lines for shock: harms exceed benefits (EVERDAC trial)

Does this remove yet another brick in the wall of critical care dogma?

Nov 3, 2025 • PulmCCM

The Latest in Critical Care: October 13, 2025

EVIDENCE trial post-cardiac arrest; Lateral positioning to prevent postop hypoxemia; European IV fluids guideline; antibiotic prophylaxis for variceal…

Oct 13, 2025 • PulmCCM

Guideline Update: Transfuse patients with acute MI to Hb ≥10 g/dL (AABB)

A third professional society agrees on risks of restricting transfusion in ACS

Oct 8, 2025 • PulmCCM

The Latest in Critical Care: September 29, 2025

Continuous vs bolus vasopressors in surgery; Hypothermia for ischemic stroke; stem cells for ARDS; intensive BP control for ICH; more

Sep 29, 2025 • PulmCCM

The Real-World Boards: Question #12

A 42-year-old woman with aneurysmal subarachnoid hemorrhage becomes unresponsive

Sep 26, 2025 • PulmCCM

Cardiology Update, 9/17/25

Highlights from the European Society of Cardiology 2025 meeting

Sep 17, 2025 • PulmCCM

The Latest in Critical Care: September 10, 2025

ANGEL-TNK, HIT antibodies are monoclonal, Metformin for Covid, vitamin C for sepsis in kids, iloprost for septic shock

Sep 10, 2025 • PulmCCM

Should "provoked" PEs get prolonged anticoagulation?

HI-PRO trial for long-term apixaban succeeds on both medical and business levels

Sep 8, 2025 • PulmCCM

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts